Generic Drugs Market Size, Global Trends, Demand & Growth

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Generic Drugs Market Size Analysis

Global Generic Drugs Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Simple Generics
    1. By Value
  3. Biosimilars
    1. By Value
  4. Specialty Generics brand
    1. By Value
2. By Therapeutic Application
  1. Introduction
    1. Therapeutic Application By Value
  2. Non Communicable
    1. By Value
    2. Sexually Transmitted Diseases
      1. Sexually Transmitted Diseases By Value
    3. Influenza
      1. Influenza By Value
    4. Malaria
      1. Malaria By Value
    5. Others
      1. Others By Value
  3. Communicable
    1. By Value
    2. Cardiovascular Diseases
      1. Cardiovascular Diseases By Value
    3. Central Nervous System (CNS)
      1. Central Nervous System (CNS) By Value
    4. Diabetes
      1. Diabetes By Value
    5. Cancer
      1. Cancer By Value
    6. Respiratory
      1. Respiratory By Value
    7. Others
      1. Others By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Topical
    1. By Value
  5. Others
    1. By Value
4. By Mode of Sale
  1. Introduction
    1. Mode of Sale By Value
  2. Prescription
    1. By Value
  3. Over-the-counter (OTC)
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Retail Pharmacies
    1. By Value
  3. Online Pharmacies
    1. By Value
  4. Hospital Pharmacies
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Simple Generics
    1. By Value
  3. Biosimilars
    1. By Value
  4. Specialty Generics brand
    1. By Value
2. By Therapeutic Application
  1. Introduction
    1. Therapeutic Application By Value
  2. Non Communicable
    1. By Value
    2. Sexually Transmitted Diseases
      1. Sexually Transmitted Diseases By Value
    3. Influenza
      1. Influenza By Value
    4. Malaria
      1. Malaria By Value
    5. Others
      1. Others By Value
  3. Communicable
    1. By Value
    2. Cardiovascular Diseases
      1. Cardiovascular Diseases By Value
    3. Central Nervous System (CNS)
      1. Central Nervous System (CNS) By Value
    4. Diabetes
      1. Diabetes By Value
    5. Cancer
      1. Cancer By Value
    6. Respiratory
      1. Respiratory By Value
    7. Others
      1. Others By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Topical
    1. By Value
  5. Others
    1. By Value
4. By Mode of Sale
  1. Introduction
    1. Mode of Sale By Value
  2. Prescription
    1. By Value
  3. Over-the-counter (OTC)
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Retail Pharmacies
    1. By Value
  3. Online Pharmacies
    1. By Value
  4. Hospital Pharmacies
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Simple Generics
    1. By Value
  3. Biosimilars
    1. By Value
  4. Specialty Generics brand
    1. By Value
2. By Therapeutic Application
  1. Introduction
    1. Therapeutic Application By Value
  2. Non Communicable
    1. By Value
    2. Sexually Transmitted Diseases
      1. Sexually Transmitted Diseases By Value
    3. Influenza
      1. Influenza By Value
    4. Malaria
      1. Malaria By Value
    5. Others
      1. Others By Value
  3. Communicable
    1. By Value
    2. Cardiovascular Diseases
      1. Cardiovascular Diseases By Value
    3. Central Nervous System (CNS)
      1. Central Nervous System (CNS) By Value
    4. Diabetes
      1. Diabetes By Value
    5. Cancer
      1. Cancer By Value
    6. Respiratory
      1. Respiratory By Value
    7. Others
      1. Others By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Topical
    1. By Value
  5. Others
    1. By Value
4. By Mode of Sale
  1. Introduction
    1. Mode of Sale By Value
  2. Prescription
    1. By Value
  3. Over-the-counter (OTC)
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Retail Pharmacies
    1. By Value
  3. Online Pharmacies
    1. By Value
  4. Hospital Pharmacies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Simple Generics
    1. By Value
  3. Biosimilars
    1. By Value
  4. Specialty Generics brand
    1. By Value
2. By Therapeutic Application
  1. Introduction
    1. Therapeutic Application By Value
  2. Non Communicable
    1. By Value
    2. Sexually Transmitted Diseases
      1. Sexually Transmitted Diseases By Value
    3. Influenza
      1. Influenza By Value
    4. Malaria
      1. Malaria By Value
    5. Others
      1. Others By Value
  3. Communicable
    1. By Value
    2. Cardiovascular Diseases
      1. Cardiovascular Diseases By Value
    3. Central Nervous System (CNS)
      1. Central Nervous System (CNS) By Value
    4. Diabetes
      1. Diabetes By Value
    5. Cancer
      1. Cancer By Value
    6. Respiratory
      1. Respiratory By Value
    7. Others
      1. Others By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Topical
    1. By Value
  5. Others
    1. By Value
4. By Mode of Sale
  1. Introduction
    1. Mode of Sale By Value
  2. Prescription
    1. By Value
  3. Over-the-counter (OTC)
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Retail Pharmacies
    1. By Value
  3. Online Pharmacies
    1. By Value
  4. Hospital Pharmacies
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Simple Generics
  1. By Value
3. Biosimilars
  1. By Value
4. Specialty Generics brand
  1. By Value
By Therapeutic Application
1. Introduction
  1. Therapeutic Application By Value
2. Non Communicable
  1. By Value
  2. Sexually Transmitted Diseases
    1. Sexually Transmitted Diseases By Value
  3. Influenza
    1. Influenza By Value
  4. Malaria
    1. Malaria By Value
  5. Others
    1. Others By Value
3. Communicable
  1. By Value
  2. Cardiovascular Diseases
    1. Cardiovascular Diseases By Value
  3. Central Nervous System (CNS)
    1. Central Nervous System (CNS) By Value
  4. Diabetes
    1. Diabetes By Value
  5. Cancer
    1. Cancer By Value
  6. Respiratory
    1. Respiratory By Value
  7. Others
    1. Others By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Parenteral
  1. By Value
4. Topical
  1. By Value
5. Others
  1. By Value
By Mode of Sale
1. Introduction
  1. Mode of Sale By Value
2. Prescription
  1. By Value
3. Over-the-counter (OTC)
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Retail Pharmacies
  1. By Value
3. Online Pharmacies
  1. By Value
4. Hospital Pharmacies
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Simple Generics
    1. By Value
  3. Biosimilars
    1. By Value
  4. Specialty Generics brand
    1. By Value
2. By Therapeutic Application
  1. Introduction
    1. Therapeutic Application By Value
  2. Non Communicable
    1. By Value
    2. Sexually Transmitted Diseases
      1. Sexually Transmitted Diseases By Value
    3. Influenza
      1. Influenza By Value
    4. Malaria
      1. Malaria By Value
    5. Others
      1. Others By Value
  3. Communicable
    1. By Value
    2. Cardiovascular Diseases
      1. Cardiovascular Diseases By Value
    3. Central Nervous System (CNS)
      1. Central Nervous System (CNS) By Value
    4. Diabetes
      1. Diabetes By Value
    5. Cancer
      1. Cancer By Value
    6. Respiratory
      1. Respiratory By Value
    7. Others
      1. Others By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Parenteral
    1. By Value
  4. Topical
    1. By Value
  5. Others
    1. By Value
4. By Mode of Sale
  1. Introduction
    1. Mode of Sale By Value
  2. Prescription
    1. By Value
  3. Over-the-counter (OTC)
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Retail Pharmacies
    1. By Value
  3. Online Pharmacies
    1. By Value
  4. Hospital Pharmacies
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Generic Drugs Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Teva Pharmaceutical Industries Ltd
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Sandoz (a Novartis division)
Sun Pharmaceutical Industries Ltd
Mylan N.V. (now part of Viatris)
Amgen Inc
Hikma Pharmaceuticals
Aurobindo Pharma
Reddy's Laboratories
Glenmark Pharmaceuticals
Zydus Cadila
Stada Arzneimittel AG
Cipla Ltd.
Fresenius Kabi AG
Lupin Pharmaceuticals

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment